Press Releases

Press Releases
  Date Title View
Sep 12, 2003
SAN DIEGO, CA, September 12, 2003 - Chimerix Inc., an emerging biotechnology company developing orally available, targeted medicines from bioactive molecules, today announced that it has licensed rights from Gilead Sciences, Inc. (Nasdaq: GILD) to develop oral derivatives of Gilead's proprietary antiviral compound cidofovir, int...
Sep 9, 2003
Oct 9, 2002
Page: FirstPrevious ...
= add release to Briefcase